New shingles vaccine shows promise in Head-to-Head trial
NCT ID NCT05304351
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study tests a new shingles vaccine called CRV-101 against the current vaccine, Shingrix, in adults aged 50 and older. The goal is to see if CRV-101 is as safe and triggers a similar immune response. About 1,500 participants will receive either the new vaccine or Shingrix and be monitored for side effects and antibody levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Curevo Investigational Site
Tempe, Arizona, 85281, United States
-
Curevo Investigational Site
Coral Gables, Florida, 33134, United States
-
Curevo Investigational Site
Tampa, Florida, 33616, United States
-
Curevo Investigational Site
Oak Brook, Illinois, 60523, United States
-
Curevo Investigational Site
Lenexa, Kansas, 66219, United States
-
Curevo Investigational Site
Newton, Kansas, 67114, United States
-
Curevo Investigational Site
Lexington, Kentucky, 40509, United States
-
Curevo Investigational Site
Las Vegas, Nevada, 89119, United States
-
Curevo Investigational Site
Edmond, Oklahoma, 73013, United States
-
Curevo Investigational Site
Knoxville, Tennessee, 37909, United States
-
Curevo Investigational Site
Austin, Texas, 78745, United States
-
Curevo Investigational Site
Dallas, Texas, 75251, United States
-
Curevo Investigational Site
Euless, Texas, 76040, United States
-
Curevo Investigational Site
Salt Lake City, Utah, 84107, United States
Conditions
Explore the condition pages connected to this study.